Brainsway Stock In The News

BWAY Stock  USD 9.87  0.19  1.96%   
Our overall analysis of Brainsway's news coverage and content from conventional and social sources shows investors' bearish mood towards Brainsway. The specific impact of Brainsway news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Brainsway's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Brainsway headlines in addition to utilizing other, more conventional financial analysis modules. Check out Brainsway Backtesting and Brainsway Hype Analysis.
For more information on how to buy Brainsway Stock please use our How to Invest in Brainsway guide.

Brainsway Today Top News and Investor Outlook

Yahoo News
7 High-Growth Stocks to Snag for Spectacular Returns in 2024
https://finance.yahoo.com/news/7-high-growth-stocks-snag-205141046.html
 Bullish
Yahoo News
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
https://finance.yahoo.com/news/biotech-stocks-fire-top-3-133227963.html
 Bullish
Yahoo News
7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
https://finance.yahoo.com/news/7-under-radar-stocks-gearing-121000115.html
 Bullish
Yahoo News
Market Mavericks: 3 Stocks That Could Turn $10K into $100K by 2027
https://finance.yahoo.com/news/market-mavericks-3-stocks-could-182912931.html
 Bullish
Macroaxis News: globenewswire.com
Louisiana Insurer Expands Deep TMSâ„¢ Access for 1.9 Million Covered Lives
https://www.globenewswire.com/news-release/2023/11/20/2783144/17676/en/Louisiana-Insurer-Expands-Deep-TMS-Access-for-1-9-Million-Covered-Lives.html
 Neutral
Macroaxis News: globenewswire.com
BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights
https://www.globenewswire.com/news-release/2023/11/15/2780920/17676/en/BrainsWay-Reports-Third-Quarter-2023-Financial-Results-and-Operational-Highlights.html
 Neutral
Macroaxis News: globenewswire.com
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
https://www.globenewswire.com/news-release/2023/11/02/2772233/17676/en/Clinical-TMS-Society-Publishes-First-Coverage-Recommendations-for-the-Treatment-of-Smoking-Addiction.html
 Neutral
Macroaxis News: globenewswire.com
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
https://www.globenewswire.com/news-release/2023/11/01/2771104/17676/en/BrainsWay-to-Report-Third-Quarter-2023-Financial-Results-on-November-15-2023.html
 Neutral
Macroaxis News: globenewswire.com
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMSâ„¢) for Depression
https://www.globenewswire.com/news-release/2023/10/16/2760521/17676/en/BrainsWay-Announces-Publication-of-Study-Data-on-Accelerated-Deep-Transcranial-Magnetic-Stimulation-Deep-TMS-for-Depression.html
 Neutral
Macroaxis News: globenewswire.com
BrainsWay Announces Presentation of Two Deep TMSâ„¢ Posters at Upcoming World Congress of Psychiatry
https://www.globenewswire.com/news-release/2023/09/27/2750314/17676/en/BrainsWay-Announces-Presentation-of-Two-Deep-TMS-Posters-at-Upcoming-World-Congress-of-Psychiatry.html
 Neutral

Brainsway Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Brainsway and other traded companies coverage with news coverage. We help investors stay connected with Brainsway headlines for the 1st of December to make an informed investment decision based on correlating the impacts of news items on Brainsway Stock performance. Please note that trading solely based on the Brainsway hype is not for everyone as timely availability and quick action are needed to avoid losses.
Brainsway's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Brainsway investors visualize upcoming and past events in order to time the market based on Brainsway noise-free hype analysis.
Brainsway stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Brainsway earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Brainsway that are available to investors today. That information is available publicly through Brainsway media outlets and privately through word of mouth or via Brainsway internal channels. However, regardless of the origin, that massive amount of Brainsway data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainsway news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainsway relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainsway's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainsway alpha.

Brainsway Largest EPS Surprises

Earnings surprises can significantly impact Brainsway's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-13
2024-09-300.010.020.01100 
2023-11-15
2023-09-30-0.03-0.020.0133 
2023-08-09
2023-06-30-0.09-0.1-0.0111 
2022-03-09
2021-12-31-0.05-0.040.0120 
2020-11-18
2020-09-30-0.07-0.08-0.0114 
2024-03-06
2023-12-31-0.010.00760.0176176 
View All Earnings Estimates

Brainsway Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Brainsway Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
20th of November 2024
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
at gurufocus.com 
news
14th of November 2024
FY2024 EPS Estimates for BrainsWay Increased by Analyst
at thelincolnianonline.com 
news
5th of November 2024
BrainsWay to Release Earnings on Tuesday
at thelincolnianonline.com 
news
28th of October 2024
Treace Medical Concepts versus BrainsWay Head to Head Contrast
at thelincolnianonline.com 
zacks News
21st of October 2024
Wall Street Analysts Believe Brainsway Could Rally 32.01 percent Heres is How to Trade
at zacks.com 
Gurufocus Stories at Macroaxis
17th of October 2024
BrainsWay Ltd Trading 6.25 percent Higher on Oct 17
at gurufocus.com 
zacks News
15th of October 2024
Are Medical Stocks Lagging Brainsway This Year
at zacks.com 
zacks News
4th of October 2024
Brainsway Ltd. Sponsored ADR Hits Fresh High Is There Still Room to Run
at zacks.com 
zacks News
1st of October 2024
Brainsway Soars 14.5 percent Is Further Upside Left in the Stock
at zacks.com 
news
20th of September 2024
BrainsWay Rating Reiterated by HC Wainwright
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brainsway in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brainsway's short interest history, or implied volatility extrapolated from Brainsway options trading.

Additional Tools for Brainsway Stock Analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.